Medicinal cannabis prescriptions in Australia are issued by registered medical practitioners within a regulated clinical framework.
Access is not available through general retail and requires an assessment to determine whether this approach may be appropriate.
To better understand how access works in Australia, it is helpful to review the broader pathways involved.
Medicinal cannabis prescribing is governed by national regulatory systems designed to ensure appropriate oversight.
Practitioners may prescribe through:
Special Access Scheme (SAS)
Authorised Prescriber pathways
These frameworks ensure that prescribing decisions are made on a case-by-case basis and align with clinical standards.
Patients often explore medicinal cannabis access pathways in Australia to understand how prescriptions are managed.
A prescription can only be issued following an assessment conducted by a qualified practitioner.
This includes reviewing:
medical history
current treatments
overall health considerations
This evaluation forms part of a structured consultation process used to determine suitability.
Not all individuals will be considered appropriate for this approach.
Each case is assessed individually, and any prescribing decision is based on clinical judgement and regulatory requirements.
Understanding the consultation pathway can help clarify how practitioners make these decisions.
Where appropriate, a practitioner may issue a prescription and recommend follow-up consultations.
Follow-up allows practitioners to:
review patient progress
monitor outcomes
adjust treatment plans if required
You can learn more about the consultation process for medicinal cannabis to understand how follow-up care is managed.
If you would like to understand whether this pathway may be appropriate, the next step is to speak with a qualified practitioner.